Cozad Asset Management’s Idexx Laboratories IDXX Stock Holding History

Cozad Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-297	Closed	-$201K	–	428
2025 Q4	$201K	Buy	+297	New	+$202K	0.02%	416
2022 Q1	–	Sell	-341	Closed	-$225K	–	361
2021 Q4	$225K	Hold	341	–	–	0.03%	318
2021 Q3	$212K	Hold	341	–	–	0.03%	326
2021 Q2	$215K	Buy	+341	New	+$188K	0.03%	325

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cozad Asset Management's IDXX Position: Q1 2026 in Review

Cozad Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 297 shares — an estimated $201K sold.

Cozad Asset Management first reported a position in IDXX in Q2 2021 and held it in 4 quarters. The position peaked at $225K in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Cozad Asset Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Cozad Asset Management sold 297 Idexx Laboratories shares in Q1 2026, an estimated $201K.
Cozad Asset Management first reported a position in Idexx Laboratories in Q2 2021 and held it in 4 quarters.
Cozad Asset Management's Idexx Laboratories position peaked at $225K in Q4 2021.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.